University of California, San Diego
ICOC Committed funds:
Awards as PI
|Comprehensive Grant||Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells||$2,570,000|
|Early Translational III||Human ES cell based therapy of heart failure without allogenic immune rejection||$1,857,600|
|Early Translational I||Developing induced pluripotent stem cells into human therapeutics and disease models||$5,165,028|
|Transplantation Immunology||Induction of immune tolerance to human embryonic stem cell-derived allografts||$1,193,292|
Disease research and drug development models based on genetically altered human embryonic stem cells.
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.